miR-217 is an oncogene that enhances the germinal center reaction

Blood. 2014 Jul 10;124(2):229-39. doi: 10.1182/blood-2013-12-543611. Epub 2014 May 21.

Abstract

microRNAs are a class of regulators of gene expression that have been shown critical for a great number of biological processes; however, little is known of their role in germinal center (GC) B cells. Although the GC reaction is crucial to ensure a competent immune response, GC B cells are also the origin of most human lymphomas, presumably due to bystander effects of the immunoglobulin gene remodeling that takes place at these sites. Here we report that miR-217 is specifically upregulated in GC B cells. Gain- and loss-of-function mouse models reveal that miR-217 is a positive modulator of the GC response that increases the generation of class-switched antibodies and the frequency of somatic hypermutation. We find that miR-217 down-regulates the expression of a DNA damage response and repair gene network and in turn stabilizes Bcl-6 expression in GC B cells. Importantly, miR-217 overexpression also promotes mature B-cell lymphomagenesis; this is physiologically relevant as we find that miR-217 is overexpressed in aggressive human B-cell lymphomas. Therefore, miR-217 provides a novel molecular link between the normal GC response and B-cell transformation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / pathology
  • B-Lymphocytes / physiology
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / pathology
  • Cells, Cultured
  • DNA Damage / genetics
  • DNA Repair / genetics
  • Gene Regulatory Networks
  • Germinal Center / physiology*
  • Lymphoma / genetics
  • Lymphoma / metabolism
  • Mice
  • Mice, Transgenic
  • MicroRNAs / physiology*
  • Microarray Analysis
  • Oncogenes / physiology*
  • Proto-Oncogene Proteins c-bcl-6 / genetics

Substances

  • MIRN-217 microRNA, mouse
  • MicroRNAs
  • Proto-Oncogene Proteins c-bcl-6